Published in Hum Genet on April 01, 1991
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
Central obesity, insulin resistance, syndrome X, lipoprotein(a), and cardiovascular risk in Indians, Malays, and Chinese in Singapore. J Epidemiol Community Health (1997) 1.73
Lipoprotein(a): an elusive cardiovascular risk factor. Arterioscler Thromb Vasc Biol (2004) 1.48
Genome-wide association study of plasma lipoprotein(a) levels identifies multiple genes on chromosome 6q. J Lipid Res (2009) 1.34
The Apo(a) gene is the major determinant of variation in plasma Lp(a) levels in African Americans. Am J Hum Genet (1997) 1.17
Is South Asian ethnicity an independent cardiovascular risk factor? Can J Cardiol (2006) 1.07
Comparative analysis of the apo(a) gene, apo(a) glycoprotein, and plasma concentrations of Lp(a) in three ethnic groups. Evidence for no common "null" allele at the apo(a) locus. J Clin Invest (1994) 1.07
Apolipoprotein(a) phenotypes, Lp(a) concentration and plasma lipid levels in relation to coronary heart disease in a Chinese population: evidence for the role of the apo(a) gene in coronary heart disease. J Clin Invest (1992) 1.01
A pentanucleotide repeat polymorphism in the 5' control region of the apolipoprotein(a) gene is associated with lipoprotein(a) plasma concentrations in Caucasians. J Clin Invest (1995) 0.99
High levels of inflammatory biomarkers are associated with increased allele-specific apolipoprotein(a) levels in African-Americans. J Clin Endocrinol Metab (2008) 0.94
Single-nucleotide polymorphisms in LPA explain most of the ancestry-specific variation in Lp(a) levels in African Americans. PLoS One (2011) 0.94
Lipoprotein(a) in women twins: heritability and relationship to apolipoprotein(a) phenotypes. Am J Hum Genet (1992) 0.92
Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians. Transl Res (2011) 0.88
Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study). Am J Cardiol (2010) 0.86
Lipoprotein (a): structure, pathophysiology and clinical implications. Arq Bras Cardiol (2014) 0.86
Distribution of apolipoprotein(a) in the plasma from patients with lipoprotein lipase deficiency and with type III hyperlipoproteinemia. No evidence for a triglyceride-rich precursor of lipoprotein(a). J Clin Invest (1992) 0.85
LPA and PLG sequence variation and kringle IV-2 copy number in two populations. Hum Hered (2008) 0.85
Lipoprotein (a) measurements for clinical application. J Lipid Res (2015) 0.84
HIV disease activity as a modulator of lipoprotein(a) and allele-specific apolipoprotein(a) levels. Arterioscler Thromb Vasc Biol (2012) 0.84
Higher serum uric acid and lipoprotein(a) are correlated with coronary spasm. Heart Vessels (2013) 0.84
Structure, function, and genetics of lipoprotein (a). J Lipid Res (2016) 0.83
Lipoprotein(a): biology and clinical importance. Clin Biochem Rev (2004) 0.83
Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology. J Lipid Res (2016) 0.83
Causes and consequences of lipoprotein(a) abnormalities in kidney disease. Clin Exp Nephrol (2013) 0.82
The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians. Atherosclerosis (2008) 0.82
Lipoprotein (a): impact by ethnicity and environmental and medical conditions. J Lipid Res (2015) 0.81
Elevated lipoprotein(a) levels predict cardiovascular disease in type 2 diabetes mellitus: a 10-year prospective cohort study. Korean J Intern Med (2016) 0.81
Galactose-specific asialoglycoprotein receptor is involved in lipoprotein (a) catabolism. Biochem J (2003) 0.80
Enigmatic role of lipoprotein(a) in cardiovascular disease. Clin Transl Sci (2010) 0.80
Distinct metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein(a). Metabolism (2015) 0.77
Genome- and exome-wide association study of serum lipoprotein (a) in the Jackson Heart Study. J Hum Genet (2015) 0.76
Update on the NCEP ATP-III emerging cardiometabolic risk factors. BMC Med (2014) 0.76
Association between high molecular weight apolipoprotein isoforms and lipoprotein levels in advanced chronic kidney disease and the effect of hemodialysis. Indian J Nephrol (2013) 0.75
Lipoprotein(a) and HIV: Allele-Specific Apolipoprotein(a) Levels Predict Carotid Intima-Media Thickness in HIV-Infected Young Women in the Women's Interagency HIV Study. Arterioscler Thromb Vasc Biol (2017) 0.75
Lipoprotein(a) Levels Are Associated With Subclinical Calcific Aortic Valve Disease in White and Black Individuals: The Multi-Ethnic Study of Atherosclerosis. Arterioscler Thromb Vasc Biol (2016) 0.75
Serum Lipoprotein (a) Levels in Black South African Type 2 Diabetes Mellitus Patients. Oxid Med Cell Longev (2016) 0.75
An open-label comparison of the effects of simvastatin and niacin alone and combined on the lipid profile and lipoprotein (a) level in an Indian population with dyslipidemia. Curr Ther Res Clin Exp (2004) 0.75
Ethnicity and lipoprotein(a) polymorphism in Native Mexican populations. Ann Hum Biol (2006) 0.75
Lipoprotein(a) in Children of Asian Indian Descendants and Their Caucasian Neighbors: The Slovak Lipid Community Study. Indian J Clin Biochem (2012) 0.75
Lipoprotein(a): a not-so-well-known risk factor for the development of cardiovascular disease in patients with type 2 diabetes mellitus. Korean J Intern Med (2016) 0.75
Lipoprotein(a) and apolipoprotein(a) in polycystic ovary syndrome. Clin Endocrinol (Oxf) (2015) 0.75
Sequence variation within the KIV-2 copy number polymorphism of the human LPA gene in African, Asian, and European populations. PLoS One (2015) 0.75
Increased levels of lipoprotein(a) in non-smoking aortic dissection patients. Clin Exp Med (2008) 0.75
DNA sequence diversity in a 9.7-kb region of the human lipoprotein lipase gene. Nat Genet (1998) 11.70
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nat Genet (2013) 9.46
Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet (2000) 8.33
VNTR allele frequency distributions under the stepwise mutation model: a computer simulation approach. Genetics (1993) 8.22
Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels. Lancet (1974) 8.19
Haplotype structure and population genetic inferences from nucleotide-sequence variation in human lipoprotein lipase. Am J Hum Genet (1998) 7.56
A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet (1996) 6.58
Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. Am J Hum Genet (2000) 4.74
Assessing genetic linkage and association with robust components of variance approaches. Ann Hum Genet (1996) 4.41
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study. Circulation (1997) 4.41
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
Alu insertion polymorphisms and human evolution: evidence for a larger population size in Africa. Genome Res (1997) 3.73
Lactase haplotype diversity in the Old World. Am J Hum Genet (2000) 3.19
Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia. N Engl J Med (1990) 3.17
Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study. Circulation (1999) 3.08
Apolipoprotein(a) gene accounts for greater than 90% of the variation in plasma lipoprotein(a) concentrations. J Clin Invest (1992) 3.05
Polymorphism of apolipoprotein E and occurrence of dysbetalipoproteinaemia in man. Nature (1977) 3.04
Uniparental paternal disomy in a genetic cancer-predisposing syndrome. Nature (1991) 2.87
Recombinational and mutational hotspots within the human lipoprotein lipase gene. Am J Hum Genet (2000) 2.83
Polynesian genetic affinities with Southeast Asian populations as identified by mtDNA analysis. Am J Hum Genet (1995) 2.74
A novel measure of genetic distance for highly polymorphic tandem repeat loci. Mol Biol Evol (1995) 2.65
Apolipoprotein E variation at the sequence haplotype level: implications for the origin and maintenance of a major human polymorphism. Am J Hum Genet (2000) 2.62
Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study. Eur Heart J (2002) 2.60
Increased neutrophil-lymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer. Br J Cancer (2013) 2.58
Sequence diversity and large-scale typing of SNPs in the human apolipoprotein E gene. Genome Res (2000) 2.53
Studies on the amphipathic nature of the membrane proteins in Semliki Forest virus. J Mol Biol (1974) 2.37
Lp(a) glycoprotein phenotypes. Inheritance and relation to Lp(a)-lipoprotein concentrations in plasma. J Clin Invest (1987) 2.35
Switch from antagonist to agonist of the androgen receptor bicalutamide is associated with prostate tumour progression in a new model system. Br J Cancer (1999) 2.34
National Biometry Audit II. Eye (Lond) (2006) 2.26
mtDNA analysis of Nile River Valley populations: A genetic corridor or a barrier to migration? Am J Hum Genet (1999) 2.25
Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A (1998) 2.22
Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc (2001) 2.19
Lipoprotein (a) levels in diabetes mellitus: relationship to metabolic control. Ann Intern Med (1992) 2.16
Polymorphism of apolipoprotein E. II. Genetics of hyperlipoproteinemia type III. Clin Genet (1979) 2.14
Lipoprotein(a): resurrected by genetics. J Intern Med (2012) 2.12
Feature (gene) selection in gene expression-based tumor classification. Mol Genet Metab (2001) 2.08
Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J Lipid Res (1982) 2.01
DNA polymorphisms in two paraoxonase genes (PON1 and PON2) are associated with the risk of coronary heart disease. Am J Hum Genet (1998) 1.94
Genetics of the apolipoprotein E system in man. Am J Hum Genet (1980) 1.94
Changes of genetic apolipoprotein phenotypes caused by liver transplantation. Implications for apolipoprotein synthesis. J Clin Invest (1989) 1.92
Is p53 polymorphism maintained by natural selection? Hum Hered (1994) 1.92
Effects of sleep deprivation on neural circulatory control. Hypertension (2000) 1.88
The apolipoprotein E polymorphism: a comparison of allele frequencies and effects in nine populations. Am J Hum Genet (1991) 1.88
Familial hyperlipoproteinemia type III: deficiency of a specific apolipoprotein (apo E-III) in the very-low-density lipoproteins. FEBS Lett (1975) 1.87
Decline in ischaemic heart disease in Iceland and change in risk factor levels. BMJ (1991) 1.86
Protein kinase C-theta isoenzyme selective stimulation of the transcription factor complex AP-1 in T lymphocytes. Mol Cell Biol (1996) 1.86
Apolipoprotein E polymorphism in health and disease. Am Heart J (1987) 1.84
Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects. J Clin Invest (1975) 1.82
Genome-wide linkage analyses of systolic blood pressure using highly discordant siblings. Circulation (1999) 1.81
High-throughput multiplex SNP genotyping with MALDI-TOF mass spectrometry: practice, problems and promise. Hum Mutat (2001) 1.80
Polynesian origins: insights from the Y chromosome. Proc Natl Acad Sci U S A (2000) 1.79
Familial dysbetalipoproteinemia. Abnormal binding of mutant apoprotein E to low density lipoprotein receptors of human fibroblasts and membranes from liver and adrenal of rats, rabbits, and cows. J Clin Invest (1981) 1.79
Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD). Coincidence of elevated Lp(a) and MCP-1 -2518 G/G genotype in CAD patients. Atherosclerosis (2001) 1.72
Anticipation in myotonic dystrophy. I. Statistical verification based on clinical and haplotype findings. Neurology (1992) 1.70
Familial thoracic aortic aneurysms and dissections: genetic heterogeneity with a major locus mapping to 5q13-14. Circulation (2001) 1.69
Simultaneous effects of the apolipoprotein E polymorphism on apolipoprotein E, apolipoprotein B, and cholesterol metabolism. Am J Hum Genet (1988) 1.68
Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis. J Clin Invest (1991) 1.68
A molecular basis for human hypersensitivity to aminoglycoside antibiotics. Nucleic Acids Res (1993) 1.67
Comparative study on antibodies to human and bacterial 60 kDa heat shock proteins in a large cohort of patients with coronary heart disease and healthy subjects. Eur J Clin Invest (2001) 1.66
Polymorphism of apolipoprotein E. III. Effect of a single polymorphic gene locus on plasma lipid levels in man. Clin Genet (1979) 1.66
Bias of the contribution of single-locus effects to the variance of a quantitative trait. Am J Hum Genet (1986) 1.65
Variation in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation (1998) 1.65
Plasma lipid, lipoprotein cholesterol, and apoprotein distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb (1993) 1.65
Cladistic structure within the human Lipoprotein lipase gene and its implications for phenotypic association studies. Genetics (2000) 1.64
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet (2000) 1.61
Dispersion of human Y chromosome haplotypes based on five microsatellites in global populations. Genome Res (1996) 1.61
Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals. Diabetologia (2011) 1.59
APOE genotype and cognitive decline in a middle-aged cohort. Neurology (2005) 1.54
Lipoprotein(a) in renal disease. Am J Kidney Dis (1996) 1.51
Apolipoprotein E polymorphism in the Finnish population: gene frequencies and relation to lipoprotein concentrations. J Lipid Res (1986) 1.50
Computational methods for gene expression-based tumor classification. Biotechniques (2000) 1.45
Comparison of model-free linkage mapping strategies for the study of a complex trait. Genet Epidemiol (1997) 1.44
Food reduces the bioavailability of lamotrigine. Indian J Med Res (2005) 1.43
Plasma lipoprotein (a) concentration and phenotypes in diabetes mellitus. Diabetologia (1993) 1.42
Recommendations for uniform reporting of data following major trauma--the Utstein Style. An International Trauma Anaesthesia and Critical Care Society (ITACCS) initiative. Eur J Emerg Med (1999) 1.40
Catabolism of the apoprotein of low density lipoproteins by the isolated perfused rat liver. J Lipid Res (1978) 1.40
Isolation and partial characterization of an arginine-rich apolipoprotein from human plasma very-low-density lipoproteins: apolipoprotein E. Hoppe Seylers Z Physiol Chem (1975) 1.39
An insertion deletion polymorphism in the signal peptide of the human apolipoprotein B gene. Hum Genet (1990) 1.36
Positional genomic analysis identifies the beta(2)-adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation (2000) 1.36
Genetics of the quantitative Lp(a) lipoprotein trait. III. Contribution of Lp(a) glycoprotein phenotypes to normal lipid variation. Hum Genet (1989) 1.34
Defects in the low density lipoprotein receptor gene affect lipoprotein (a) levels: multiplicative interaction of two gene loci associated with premature atherosclerosis. Proc Natl Acad Sci U S A (1989) 1.34
Linkage disequilibrium between two loci (5' untranslated exon 1 and intron 5-DdeI) of the antithrombin III gene in three ethnic groups in Singapore. Hum Hered (1995) 1.33
Protein composition of Lp(a) lipoprotein from human plasma. FEBS Lett (1983) 1.32
Liquorice-induced rise in blood pressure: a linear dose-response relationship. J Hum Hypertens (2001) 1.28
Activation of lecithin: cholesterol acyltransferase by human apolipoprotein A-IV. J Biol Chem (1985) 1.27
The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration. Hum Genet (1992) 1.26
Apolipoprotein E phenotypes and hyperlipidemia. Hum Genet (1984) 1.26
Binding and partial inactivation of Staphylococcus aureus alpha-toxin by human plasma low density lipoprotein. J Biol Chem (1983) 1.26
Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis (2000) 1.25
Linkage disequilibrium structure and its impact on the localization of a candidate functional mutation. Genet Epidemiol (2001) 1.24
Male-female differences in the association between incident hip fracture and proximal femoral strength: a finite element analysis study. Bone (2011) 1.24
Structure-function analysis of yeast mRNA cap methyltransferase and high-copy suppression of conditional mutants by AdoMet synthase and the ubiquitin conjugating enzyme Cdc34p. Genetics (2000) 1.22
Abnormal calcium metabolism in normocalcaemic sarcoidosis. Br Med J (1976) 1.22
Allele frequency distribution of the (TG)n(AG)m microsatellite in the apolipoprotein C-II gene. Genomics (1992) 1.20